Potential therapies could include precise genetic targeting of the GLUT4 pathway or dietary modifications to fine-tune glucose levels, ensuring an optimal environment for neurogenesis.
Stanford research uncovers glucose’s role in boosting neurogenesis, offering insights into brain aging interventions.
A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of reprogrammed neurons found by other researchers.
Wearable devices like smartwatches and fitness trackers interact with parts of our bodies to measure and learn from internal processes, such as our heart rate or sleep stages.
Now, MIT researchers have developed wearable devices that may be able to perform similar functions for individual cells inside the body.
These battery-free, subcellular-sized devices, made of a soft polymer, are designed to gently wrap around different parts of neurons, such as axons and dendrites, without damaging the cells, upon wireless actuation with light. By snugly wrapping neuronal processes, they could be used to measure or modulate a neuron’s electrical and metabolic activity at a subcellular level.
Summary: Neural crest stem cells, a rare type found in skin and other tissues, are uniquely capable of reprogramming into different cell types, challenging the prevailing belief that any mature cell can be reprogrammed. The study reveals that cellular reprogramming is likely limited to these specialized stem cells rather than all mature cells.
Neural crest stem cells are present in skin, bone, and connective tissue, with a natural predisposition for transformation due to their origin in embryonic development. This finding could reshape strategies for stem cell therapies, emphasizing the role of neural crest cells in treating neurodegenerative diseases. The team hopes their work will refine cell reprogramming approaches and inspire further research into the specific potentials of stem cell types.
In his most recent book, neuroscientist and psychoanalyst Mark Solms tackles a philosophical puzzle: Why should we have consciousness? Why does life feel like something at all?
A key challenge in the effort to link brain activity with behavior is that brain activity, measured by functional magnetic resonance imaging (fMRI), for instance, is extraordinarily complex. That complexity can make it difficult to find recurring activity patterns across different people or within individuals.
In a new study, Yale researchers were able to take fMRI data, reduce its complexity, and in doing so, uncover stable patterns of activity shared across more than 300 different people. The findings, researchers say, are a promising step forward in uncovering biomarkers for psychiatric disorders.
The study was published Sept. 24 in the journal PLOS Biology.
—————–Support the channel———–
Patreon: https://www.patreon.com/thedissenter.
PayPal: paypal.me/thedissenter.
——————Follow me on——————–
Facebook: https://www.facebook.com/thedissenteryt/
Twitter: https://twitter.com/TheDissenterYT
Alzheimer’s disease, fronto temporal dementia and progressive supra nuclear palsy. Using this study design, the investigators found four genes that marked vulnerable neurons across all three disorders, highlighting pathways that could be used to develop new therapeutic approaches.
The discovery of genes that marked vulnerable neurons could open options for therapeutic approaches.
At some point in your life, you must’ve experienced a lightbulb moment when an amazing idea just popped into your head out of nowhere. But what is your brain doing during these brief periods of creativity?
Researchers from the University of Utah Health and Baylor College of Medicine looked into the origin of creative thinking in the brain. They found that different parts of the brain work together to produce creative ideas, not just one particular area.
“Unlike motor function or vision, they’re not dependent on one specific location in the brain,” Ben Shofty, the senior author of the study and an assistant professor of neurosurgery at the Spencer Fox Eccles School of Medicine, said. “There’s not a creativity cortex.”
